Category: Press Release - Page 79 - Psychedelic Alpha

Read more about the article Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development

Field Trip Receives Notice of Allowance for US Patent Application Covering FT-104 (Isoprocin Glutarate), its Novel Psychedelic Molecule in Development

Post published:January 11, 2022
Post category:Press Release

Read more about the article Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Wesana Health Granted US FDA Pre-IND Meeting for SANA-013

Post published:January 11, 2022
Post category:Press Release

Read more about the article Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure Psychedelic Effects on the Brain

Institutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure Psychedelic Effects on the Brain

Post published:January 11, 2022
Post category:Press Release

Read more about the article Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

Awakn Life Sciences Announces Positive Results from Phase II A/B Ketamine-Assisted Therapy for Treatment of Alcohol Use Disorder Trial

Post published:January 11, 2022
Post category:Press Release

Read more about the article Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds

Mydecine Achieves Innovative Supercomputing Artificial Intelligence Modeling in Psychedelic Drug Development Enabling Quick Screening of Billions of Compounds

Post published:January 10, 2022
Post category:Press Release

Read more about the article Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million Strategic Credit Facility Option in Partnership with Comerica Bank

Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million Strategic Credit Facility Option in Partnership with Comerica Bank

Post published:January 10, 2022
Post category:Press Release

Read more about the article Mydecine Innovations Group Engages JBN Partners, LLC for Marketing Services

Mydecine Innovations Group Engages JBN Partners, LLC for Marketing Services

Post published:January 7, 2022
Post category:Press Release

Read more about the article Stephen Hurst Resigns from MindMed Board of Directors

Stephen Hurst Resigns from MindMed Board of Directors

Post published:January 7, 2022
Post category:Press Release

Read more about the article Cybin Announces Additional Adelia Milestone Achievement

Cybin Announces Additional Adelia Milestone Achievement

Post published:January 6, 2022
Post category:Press Release

Read more about the article Levitee Labs Announces Medical Advisory Board

Levitee Labs Announces Medical Advisory Board

Post published:January 6, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.